U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from Books

Items: 2

1.
A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome
David R. Strayer, William A. Carter, Bruce C. Stouch, Staci R. Stevens, Lucinda Bateman, Paul J. Cimoch, Charles W. Lapp, Daniel L. Peterson, the Chronic Fatigue Syndrome AMP-516 Study Group, William M. Mitchell
PLoS One. 2012; 7(3): e31334. Published online 2012 Mar 14. doi: 10.1371/journal.pone.0031334
PMCID:
PMC3303772
AbstractArticlePDF–305K
2.
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study
Øystein Fluge, Ove Bruland, Kristin Risa, Anette Storstein, Einar K. Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl, Harald Nyland, Olav Mella
PLoS One. 2011; 6(10): e26358. Published online 2011 Oct 19. doi: 10.1371/journal.pone.0026358
PMCID:
PMC3198463
AbstractArticlePDF–977K

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center